227 related articles for article (PubMed ID: 26405844)
1. The composition and daily variation of microparticles in whole blood in stable coronary artery disease.
Christersson C; Lindahl B; Siegbahn A
Scand J Clin Lab Invest; 2016; 76(1):25-32. PubMed ID: 26405844
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of microparticles in whole blood by multicolour flow cytometry assay.
Christersson C; Johnell M; Siegbahn A
Scand J Clin Lab Invest; 2013 Apr; 73(3):229-39. PubMed ID: 23452203
[TBL] [Abstract][Full Text] [Related]
3. Microparticles during long-term follow-up after acute myocardial infarction. Association to atherosclerotic burden and risk of cardiovascular events.
Christersson C; Thulin Å; Siegbahn A
Thromb Haemost; 2017 Jul; 117(8):1571-1581. PubMed ID: 28424820
[TBL] [Abstract][Full Text] [Related]
4. Small-size circulating microparticles in acute coronary syndromes: relevance to fibrinolytic status, reparative markers and outcomes.
Montoro-García S; Shantsila E; Tapp LD; López-Cuenca A; Romero AI; Hernández-Romero D; Orenes-Piñero E; Manzano-Fernández S; Valdés M; Marín F; Lip GY
Atherosclerosis; 2013 Apr; 227(2):313-22. PubMed ID: 23415055
[TBL] [Abstract][Full Text] [Related]
5. Number of microparticles generated during acute myocardial infarction and stable angina correlates with platelet activation.
Stępień E; Stankiewicz E; Zalewski J; Godlewski J; Zmudka K; Wybrańska I
Arch Med Res; 2012 Jan; 43(1):31-5. PubMed ID: 22306248
[TBL] [Abstract][Full Text] [Related]
6. Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease.
Mobarrez F; He S; Bröijersen A; Wiklund B; Antovic A; Antovic J; Egberg N; Jörneskog G; Wallén H
Thromb Haemost; 2011 Aug; 106(2):344-52. PubMed ID: 21614411
[TBL] [Abstract][Full Text] [Related]
7. Increased circulating endothelial microparticles in COPD patients: a potential biomarker for COPD exacerbation susceptibility.
Takahashi T; Kobayashi S; Fujino N; Suzuki T; Ota C; He M; Yamada M; Suzuki S; Yanai M; Kurosawa S; Yamaya M; Kubo H
Thorax; 2012 Dec; 67(12):1067-74. PubMed ID: 22843558
[TBL] [Abstract][Full Text] [Related]
8. Activity of Tissue Factor in Microparticles Produced in vitro by Endothelial Cells, Monocytes, Granulocytes, and Platelets.
Khaspekova SG; Antonova OA; Shustova ON; Yakushkin VV; Golubeva NV; Titaeva EV; Dobrovolsky AB; Mazurov AV
Biochemistry (Mosc); 2016 Feb; 81(2):114-21. PubMed ID: 27260391
[TBL] [Abstract][Full Text] [Related]
9. Involvement of microparticles in diabetic vascular complications.
Tsimerman G; Roguin A; Bachar A; Melamed E; Brenner B; Aharon A
Thromb Haemost; 2011 Aug; 106(2):310-21. PubMed ID: 21713319
[TBL] [Abstract][Full Text] [Related]
10. Small-size Microparticles as Indicators of Acute Decompensated State in Ischemic Heart Failure.
Montoro-García S; Shantsila E; Wrigley BJ; Tapp LD; Abellán Alemán J; Lip GY
Rev Esp Cardiol (Engl Ed); 2015 Nov; 68(11):951-8. PubMed ID: 25819989
[TBL] [Abstract][Full Text] [Related]
11. Unexplained pregnancy loss: a marker of basal endothelial dysfunction?
Pasquier E; De Saint Martin L; Bohec C; Collet M; Dignat George F; Mottier D
Fertil Steril; 2013 Oct; 100(4):1013-7. PubMed ID: 23830152
[TBL] [Abstract][Full Text] [Related]
12. Circulating cell-derived microparticles in severe preeclampsia and in fetal growth restriction.
Alijotas-Reig J; Palacio-Garcia C; Farran-Codina I; Ruiz-Romance M; Llurba E; Vilardell-Tarres M
Am J Reprod Immunol; 2012 Feb; 67(2):140-51. PubMed ID: 21992597
[TBL] [Abstract][Full Text] [Related]
13. Endothelial Cell-Derived Microparticles from Patients with Obstructive Sleep Apnea Hypoxia Syndrome and Coronary Artery Disease Increase Aortic Endothelial Cell Dysfunction.
Jia L; Fan J; Cui W; Liu S; Li N; Lau WB; Ma X; Du J; Nie S; Wei Y
Cell Physiol Biochem; 2017; 43(6):2562-2570. PubMed ID: 29130961
[TBL] [Abstract][Full Text] [Related]
14. Use of immuno-magnetic beads for direct capture of nanosized microparticles from plasma.
Yuana Y; Osanto S; Bertina RM
Blood Coagul Fibrinolysis; 2012 Apr; 23(3):244-50. PubMed ID: 22343682
[TBL] [Abstract][Full Text] [Related]
15. Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles?
Campello E; Radu CM; Duner E; Lombardi AM; Spiezia L; Bendo R; Ferrari S; Simioni P; Fabris F
Cytometry B Clin Cytom; 2018 Mar; 94(2):334-341. PubMed ID: 28052584
[TBL] [Abstract][Full Text] [Related]
16. Circulating microparticles in patients with antiphospholipid antibodies: characterization and associations.
Chaturvedi S; Cockrell E; Espinola R; Hsi L; Fulton S; Khan M; Li L; Fonseca F; Kundu S; McCrae KR
Thromb Res; 2015 Jan; 135(1):102-8. PubMed ID: 25467081
[TBL] [Abstract][Full Text] [Related]
17. Fluorescent particles in the antibody solution result in false TF- and CD14-positive microparticles in flow cytometric analysis.
Aass HC; Øvstebø R; Trøseid AM; Kierulf P; Berg JP; Henriksson CE
Cytometry A; 2011 Dec; 79(12):990-9. PubMed ID: 21990118
[TBL] [Abstract][Full Text] [Related]
18. Effect of glycoprotein IIb/IIIa antagonist abciximab on monocyte-platelet aggregates and tissue factor expression.
Steiner S; Seidinger D; Huber K; Kaun C; Minar E; Kopp CW
Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1697-702. PubMed ID: 12869353
[TBL] [Abstract][Full Text] [Related]
19. Differential ability of tissue factor antibody clones on detection of tissue factor in blood cells and microparticles.
Basavaraj MG; Olsen JO; Østerud B; Hansen JB
Thromb Res; 2012 Sep; 130(3):538-46. PubMed ID: 22728024
[TBL] [Abstract][Full Text] [Related]
20. Platelet-monocyte cross talk and tissue factor expression in stable angina vs. unstable angina/non ST-elevation myocardial infarction.
Kopp CW; Gremmel T; Steiner S; Seidinger D; Minar E; Maurer G; Huber K
Platelets; 2011; 22(7):530-6. PubMed ID: 21557685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
